Oppenheimer Starts Evaxion Biotech (EVAX) at Outperform
Tweet
Share
E-mailGet Alerts EVAX Hot Sheet
Price: $4.13 --0%
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 9
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 9
Join SI Premium – FREE
Oppenheimer analyst Kevin DeGeeter initiates coverage on Evaxion Biotech (NASDAQ: EVAX) with a Outperform rating and a price target of $18.00.
For an analyst ratings summary and ratings history on Evaxion Biotech click here. For more ratings news on Evaxion Biotech click here.
Shares of Evaxion Biotech closed at $7.08 yesterday.
You May Also Be Interested In
- Singular Research Starts Citizens Inc. (CIA) at Buy-Long Term, 'Proven Distribution Growth'
- CLSA Starts Yokohama Rubber Co (5101:JP) at Underperform (4)
- JPMorgan Starts Accent Group Ltd. (AX1:AU) at Overweight
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
